373 related articles for article (PubMed ID: 17542716)
1. Identifying motivations and barriers to patient participation in clinical trials.
Jones JM; Nyhof-Young J; Moric J; Friedman A; Wells W; Catton P
J Cancer Educ; 2006; 21(4):237-42. PubMed ID: 17542716
[TBL] [Abstract][Full Text] [Related]
2. Understanding the attitudes of the elderly towards enrolment into cancer clinical trials.
Townsley CA; Chan KK; Pond GR; Marquez C; Siu LL; Straus SE
BMC Cancer; 2006 Feb; 6():34. PubMed ID: 16466574
[TBL] [Abstract][Full Text] [Related]
3. Altruism among participants in cancer clinical trials.
Truong TH; Weeks JC; Cook EF; Joffe S
Clin Trials; 2011 Oct; 8(5):616-23. PubMed ID: 21813584
[TBL] [Abstract][Full Text] [Related]
4. Understanding the decisions of cancer clinical trial participants to enter research studies: factors associated with informed consent, patient satisfaction, and decisional regret.
Stryker JE; Wray RJ; Emmons KM; Winer E; Demetri G
Patient Educ Couns; 2006 Oct; 63(1-2):104-9. PubMed ID: 16242898
[TBL] [Abstract][Full Text] [Related]
5. Barriers and facilitators to enrollment in cancer clinical trials: qualitative study of the perspectives of clinical research associates.
Grunfeld E; Zitzelsberger L; Coristine M; Aspelund F
Cancer; 2002 Oct; 95(7):1577-83. PubMed ID: 12237928
[TBL] [Abstract][Full Text] [Related]
6. Measurement of factors influencing the participation of patients with prostate cancer in clinical trials: a Canadian perspective.
Davison BJ; So A; Goldenberg SL; Berkowitz J; Gleave ME
BJU Int; 2008 Apr; 101(8):982-7. PubMed ID: 18005198
[TBL] [Abstract][Full Text] [Related]
7. Influence of tumor type, disease status, and patient age on self-reported interest regarding participation in cancer clinical trials.
Markman M; Petersen J; Montgomery R
Cancer; 2006 Aug; 107(4):849-53. PubMed ID: 16832813
[TBL] [Abstract][Full Text] [Related]
8. Hypertensive patients' willingness to participate in placebo-controlled trials: implications for recruitment efficiency.
Halpern SD; Karlawish JH; Casarett D; Berlin JA; Townsend RR; Asch DA
Am Heart J; 2003 Dec; 146(6):985-92. PubMed ID: 14660989
[TBL] [Abstract][Full Text] [Related]
9. From information processing to behavioral intentions: exploring cancer patients' motivations for clinical trial enrollment.
Janet Yang Z; McComas K; Gay G; Leonard JP; Dannenberg AJ; Dillon H
Patient Educ Couns; 2010 May; 79(2):231-8. PubMed ID: 19748204
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials.
Lara PN; Paterniti DA; Chiechi C; Turrell C; Morain C; Horan N; Montell L; Gonzalez J; Davis S; Umutyan A; Martel CL; Gandara DR; Wun T; Beckett LA; Chen MS
J Clin Oncol; 2005 Dec; 23(36):9282-9. PubMed ID: 16361626
[TBL] [Abstract][Full Text] [Related]
11. Factors determining participation in prevention trials among systemic lupus erythematosus patients: a qualitative study.
Costenbader KH; Brome D; Blanch D; Gall V; Karlson E; Liang MH
Arthritis Rheum; 2007 Feb; 57(1):49-55. PubMed ID: 17266094
[TBL] [Abstract][Full Text] [Related]
12. Post-study aspirin intake and factors motivating participation in a colorectal cancer chemoprevention trial.
Sample DA; Sinicrope PS; Wargovich MJ; Sinicrope FA
Cancer Epidemiol Biomarkers Prev; 2002 Mar; 11(3):281-5. PubMed ID: 11895878
[TBL] [Abstract][Full Text] [Related]
13. Factors that influence a patient's decision to participate in a phase I cancer clinical trial.
Schutta KM; Burnett CB
Oncol Nurs Forum; 2000 Oct; 27(9):1435-8. PubMed ID: 11058975
[TBL] [Abstract][Full Text] [Related]
14. Patient and physician attitudes toward breast cancer clinical trials: developing interventions based on understanding barriers.
Melisko ME; Hassin F; Metzroth L; Moore DH; Brown B; Patel K; Rugo HS; Tripathy D
Clin Breast Cancer; 2005 Apr; 6(1):45-54. PubMed ID: 15899072
[TBL] [Abstract][Full Text] [Related]
15. Intention, needs, and expectations of cancer patients participating in clinical trials.
Wang LH; Tsai YF; Chen JS; Tsay PK
Cancer Nurs; 2011; 34(2):117-23. PubMed ID: 21326029
[TBL] [Abstract][Full Text] [Related]
16. Increasing minority patient participation in cancer clinical trials using oncology nurse navigation.
Holmes DR; Major J; Lyonga DE; Alleyne RS; Clayton SM
Am J Surg; 2012 Apr; 203(4):415-22. PubMed ID: 21996347
[TBL] [Abstract][Full Text] [Related]
17. Why cancer patients enter randomized clinical trials: exploring the factors that influence their decision.
Wright JR; Whelan TJ; Schiff S; Dubois S; Crooks D; Haines PT; DeRosa D; Roberts RS; Gafni A; Pritchard K; Levine MN
J Clin Oncol; 2004 Nov; 22(21):4312-8. PubMed ID: 15514372
[TBL] [Abstract][Full Text] [Related]
18. The correlation between patient characteristics and expectations of benefit from Phase I clinical trials.
Weinfurt KP; Castel LD; Li Y; Sulmasy DP; Balshem AM; Benson AB; Burnett CB; Gaskin DJ; Marshall JL; Slater EF; Schulman KA; Meropol NJ
Cancer; 2003 Jul; 98(1):166-75. PubMed ID: 12833469
[TBL] [Abstract][Full Text] [Related]
19. Participation in clinical trials as viewed by the patient: understanding cultural and emotional aspects which influence choice.
Catania C; De Pas T; Goldhirsch A; Radice D; Adamoli L; Medici M; Verri E; Marenghi C; de Braud F; Nolè F
Oncology; 2008; 74(3-4):177-87. PubMed ID: 18714166
[TBL] [Abstract][Full Text] [Related]
20. Diversity of participants in clinical trials in an academic medical center: the role of the 'Good Study Patient?'.
Joseph G; Dohan D
Cancer; 2009 Feb; 115(3):608-15. PubMed ID: 19127544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
